Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates

Medicine & Life Sciences

• Treponema pallidum 92%
• Borrelia burgdorferi 86%
• Syphilis 76%
• Vaccines 51%
• Immunization 47%
• Antigens 43%
• Rabbits 32%
• Membrane Proteins 18%
• Spirochaetales 14%
• Globus Pallidus 13%
• Histocompatibility Antigens Class II 12%
• Animals 11%
• Developed Countries 10%
• Lipoproteins 10%
• Developing Countries 10%
• Epitopes 9%
• Microscopy 9%
• Immunity 9%
• Escherichia coli 7%
• Skin 6%
• Infections 5%
• Genes 4%

Agriculture & Biology

• Treponema pallidum 100%
• Borrelia burgdorferi 82%
• vaccines 58%
• antigens 50%
• immunization 47%
• rabbits 26%
• outer membrane proteins 22%
• recombinant antigens 14%
• vaccine development 12%
• skin lesions 11%
• Spirochaetes 11%
• developed countries 10%
• adjuvants 10%
• lipoproteins 9%
• developing countries 9%
• epitopes 9%
• microscopy 8%
• vaccination 8%
• immunity 8%
• animals 8%
• immune response 8%
• lesions (animal) 7%
• Escherichia coli 6%
• pathogens 5%
• infection 5%
• testing 3%
• genes 3%
• methodology 2%

Social Sciences

• candidacy 51%
• animal 36%
• experiment 26%
• immunity 25%
• campaign 16%
• Group 6%